Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
6.96M
-
Shares change
-
-7.26K
-
Total reported value, excl. options
-
$365M
-
Value change
-
-$580K
-
Number of buys
-
87
-
Number of sells
-
-66
-
Price
-
$52.48
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q1 2025
186 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q1 2025.
IRADIMED CORP - Common Stock (IRMD) has 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.96M shares
of 12.7M outstanding shares and own 54.67% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (946K shares), Nine Ten Capital Management LLC (872K shares), VANGUARD GROUP INC (554K shares), RENAISSANCE TECHNOLOGIES LLC (502K shares), Copeland Capital Management, LLC (491K shares), GEODE CAPITAL MANAGEMENT, LLC (245K shares), DIMENSIONAL FUND ADVISORS LP (220K shares), Ranger Investment Management, L.P. (200K shares), STATE STREET CORP (176K shares), and GOLDMAN SACHS GROUP INC (169K shares).
This table shows the top 167 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.